AGP Executive Report
Last update: 8 hours agoHepatitis B Vaccine Trial: The University of Southern Denmark has reportedly approved a controversial Guinea-Bissau study, with the CDC seeking $1.6 million to support it. The trial would withhold the protective birth-dose vaccine from half of 14,000 newborns. Health advocates condemn the plan as unethical; nearly one in five people in Guinea-Bissau has hepatitis B. Regional Disease Watch: ECOWAS health and veterinary officials met in Togo to strengthen surveillance and control of cross-border animal diseases, including avian influenza, rabies and foot-and-mouth disease—threats to livelihoods and food security across West Africa.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
